Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis

NCT01301508 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic

Interventions

DRUG: AN2728 ointment, 2%
DRUG: AN2898 ointment, 1%
DRUG: AN2898 ointment vehicle
DRUG: AN2728 ointment vehicle

Sponsor

Pfizer